This website is intended for healthcare professionals only.

Hospital Pharmacy Europe     Newsletter          

Clinical

Launch of two new Joint Working Projects with national Cancer Vanguard sites
Launch of two new Joint Working Projects with national Cancer Vanguard sites
Read more
Stroke prevention drugs may help reduce dementia risk for atrial fibrillation patients
Stroke prevention drugs may help reduce dementia risk for atrial fibrillation patients
Read more
Study finds the heart can terminate AF itself after local gene therapy
Study finds the heart can terminate AF itself after local gene therapy
Read more
First potential PET tracer for Parkinson’s disease?
First potential PET tracer for Parkinson’s disease?
Read more
Digital platform to engage patients and track outcomes following orthopaedic surgery launched
Digital platform to engage patients and track outcomes following orthopaedic surgery launched
Read more
New partnership between University of Surrey and Great Ormond Street Hospital
New partnership between University of Surrey and Great Ormond Street Hospital
Read more
Omalizumab recommended in global chronic urticaria guideline
Omalizumab recommended in global chronic urticaria guideline
Read more
Launch of first breast cancer biosimilar in the UK
Launch of first breast cancer biosimilar in the UK
Read more
Diabetes tablet passes Phase III clinical trial
Diabetes tablet passes Phase III clinical trial
Read more
Treatment for rare cancer in adults supported by NICE
Treatment for rare cancer in adults supported by NICE
Read more
First liquid biopsy for the differential diagnosis of early stage lung cancer validated by study
First liquid biopsy for the differential diagnosis of early stage lung cancer validated by study
Read more
Positive CHMP opinion for pegfilgrastim delivery system granted
Positive CHMP opinion for pegfilgrastim delivery system granted
Read more
Anakinra receives positive opinion from CHMP for the treatment of Still’s disease
Anakinra receives positive opinion from CHMP for the treatment of Still’s disease
Read more
Positive opinion for expanded use of denosumab in multiple myeloma received
Positive opinion for expanded use of denosumab in multiple myeloma received
Read more
Conditional marketing authorisation for X-linked hypophosphatemia treatment in children
Conditional marketing authorisation for X-linked hypophosphatemia treatment in children
Read more

Popular articles

Exacerbations reduced by dupilumab in COPD patients with type 2 inflammation
Biobank pilot to be launched by MHRA to better understand genetics and medicines safety
Government commits to easing pressure on NHS through commercial clinical trial investment





 

Download Hospital Healthcare Europe free app

Download our app from the Apple App Store Download our app from Google Play

In official association with

HOPE Logo Footer

© Cogora 2023
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora